Investigating the mRNA expression in normal vs. tumor samples, DYRK3 (Figure 10g) and DYRK4 (Figure 10i) were found to have significantly lower methylation level compared to the control in COAD. The gene discussed is DYRK4; the disease is colon adenocarcinoma.